Literature DB >> 22200403

Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics.

Dorota Maciejewska1, Jerzy Zabinski, Pawel Kaźmierczak, Mateusz Rezler, Barbara Krassowska-Świebocka, Margaret S Collins, Melanie T Cushion.   

Abstract

A series of 20 pentamidine analogs were prepared using 2 general Schemes that evaluated heteroatoms, sulfobenzene and alkanediamide groups in the aliphatic linker and methoxy substituents attached to the benzene rings for efficacy against the fungal pathogen, Pneumocystis carinii in an ATP bioassay. All but one of the 20 bisamidines reduced the ATP content of the P. carinii over the 72 h of the assay period. The highest activities were associated with the lack of methoxy groups and the presence of the O, N and S heteroatoms. Activity (IC(50)) for compounds 1, 5, 6, 10 ranged from 1.1 to 2.13 μM. The compound 11 with similar activity (1.33 μM), bears a sulfobenzene group at a nitrogen in the aliphatic linker. The alkanediamide-linked bisbenzamidines showed a moderate inhibition of ATP. Generally, the inclusion of a heteroatom in the aliphatic linker and absence of methoxy groups at the benzene rings were associated with higher activities in this assay. Of note, most of the compounds had little to no cytotoxicity in mammalian cell cultures. Although not quite as potent as other pentamidine derivatives, these compounds hold promise for decreased side effects within the mammalian host.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200403      PMCID: PMC3273716          DOI: 10.1016/j.ejmech.2011.12.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  21 in total

1.  DNA minor groove interactions and the biological activity of 2,5-bis.

Authors:  I J Simpson; M Lee; A Kumar; D W Boykin; S Neidle
Journal:  Bioorg Med Chem Lett       Date:  2000-12-04       Impact factor: 2.823

2.  Theoretical models of pentamidine analogs activity based on their DNA minor groove complexes.

Authors:  Teresa Zołek; Dorota Maciejewska
Journal:  Eur J Med Chem       Date:  2010-01-28       Impact factor: 6.514

3.  Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii.

Authors:  M T Cushion; M Collins; B Hazra; E S Kaneshiro
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii.

Authors:  E S Kaneshiro; M S Collins; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents.

Authors:  M T Cushion; F Chen; N Kloepfer
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

6.  2,4-Diphenyl furan diamidines as novel anti-Pneumocystis carinii pneumonia agents.

Authors:  I Francesconi; W D Wilson; F A Tanious; J E Hall; B C Bender; R R Tidwell; D McCurdy; D W Boykin
Journal:  J Med Chem       Date:  1999-06-17       Impact factor: 7.446

7.  Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity.

Authors:  Tien L Huang; Jean Jacques Vanden Eynde; Annie Mayence; Margaret S Collins; Melanie T Cushion; Donna Rattendi; Indira Londono; Lakshman Mazumder; Cyrus J Bacchi; Nigel Yarlett
Journal:  Bioorg Med Chem Lett       Date:  2009-08-23       Impact factor: 2.823

Review 8.  Sterol biosynthesis and sterol uptake in the fungal pathogen Pneumocystis carinii.

Authors:  Tiffany M Joffrion; Melanie T Cushion
Journal:  FEMS Microbiol Lett       Date:  2010-10       Impact factor: 2.742

9.  Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.487

Review 10.  Preclinical drug discovery for new anti-pneumocystis compounds.

Authors:  Melanie T Cushion; Peter D Walzer
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more
  9 in total

1.  Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.

Authors:  Michael L Berger; Dorota Maciejewska; Jean Jacques Vanden Eynde; Madhusoodanan Mottamal; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler; Ivana Jarak; Ivo Piantanida; Grace Karminski-Zamola; Annie Mayence; Patrick Rebernik; Arvind Kumar; Mohamed A Ismail; David W Boykin; Tien L Huang
Journal:  Bioorg Med Chem       Date:  2015-06-14       Impact factor: 3.641

2.  Drug-likeness of linear pentamidine analogues and their impact on the hERG K+ channel - correlation with structural features.

Authors:  Teresa Żołek; Muge Qile; Paweł Kaźmierczak; Meye Bloothooft; Marcel A G van der Heyden; Dorota Maciejewska
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 3.361

3.  Probing the relationship between anti-Pneumocystis carinii activity and DNA binding of bisamidines by molecular dynamics simulations.

Authors:  Teresa Żołek; Dorota Maciejewska; Jerzy Żabiński; Paweł Kaźmierczak; Mateusz Rezler
Journal:  Molecules       Date:  2015-04-03       Impact factor: 4.411

4.  Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.

Authors:  Charlotte M J Wesseling; Cornelis J Slingerland; Shanice Veraar; Samantha Lok; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2021-11-12       Impact factor: 5.084

5.  Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity.

Authors:  D Maciejewska; J Żabiński; M Rezler; P Kaźmierczak; M S Collins; L Ficker; M T Cushion
Journal:  Medchemcomm       Date:  2017-10-05       Impact factor: 3.597

6.  Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens.

Authors:  Ana Gomes; Ricardo Ferraz; Lauren Ficker; Margaret S Collins; Cristina Prudêncio; Melanie T Cushion; Cátia Teixeira; Paula Gomes
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

7.  Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study.

Authors:  Dimitri Stanicki; Muriel Pottier; Nausicaa Gantois; Claire Pinçon; Delphine Forge; Isabelle Mahieu; Sébastien Boutry; Jean Jacques Vanden Eynde; Anna Martinez; Eduardo Dei-Cas; El-Moukhtar Aliouat
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-01

8.  Functional Characterization of Pneumocystis carinii Inositol Transporter 1.

Authors:  Melanie T Cushion; Margaret S Collins; Thomas Sesterhenn; Aleksey Porollo; Anish Kizhakkekkara Vadukoot; Edward J Merino
Journal:  MBio       Date:  2016-12-13       Impact factor: 7.867

9.  Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.

Authors:  Luz P Quebrada Palacio; Mariela N González; Yolanda Hernandez-Vasquez; Alina E Perrone; Adriana Parodi-Talice; Jacqueline Bua; Miriam Postan
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.